MoneyWorks4Me

Krebs Biochem.&Inds reports Profit after tax of Rs -94.24 Mln, in the June 2021 quarter

30 Jul 2021 Evaluate
A decrease of about -41.61% in the sales to Rs. 67.55 millions was observed for the quarter ended June 2021. The sales stood at Rs. 115.69 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2021 is Rs. -94.24 millions as compared to Net Loss of Rs. -67.21 millions of corresponding quarter ended June 2020 Operating profit Margin for the quarter ended June 2021 further decreased to -64.96% as compared to -42.52% of corresponding quarter ended June 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202103 202003 % Var
Sales 67.55 115.69 -41.61 67.55 115.69 -41.61 537.00 334.12 60.72
Other Income 0.30 0.50 -40.00 0.30 0.50 -40.00 6.21 3.65 70.14
PBIDT -64.96 -42.52 52.78 -64.96 -42.52 52.78 -169.56 -182.65 -7.17
Interest 15.12 12.32 22.73 15.12 12.32 22.73 62.79 59.28 5.92
PBDT -80.08 -54.84 46.02 -80.08 -54.84 46.02 -232.35 -241.93 -3.96
Depreciation 14.16 12.37 14.47 14.16 12.37 14.47 51.24 46.79 9.51
PBT -94.24 -67.21 40.22 -94.24 -67.21 40.22 -283.59 -288.72 -1.78
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -94.24 -67.21 40.22 -94.24 -67.21 40.22 -283.59 -288.72 -1.78
Equity 215.61 196.21 9.89 215.61 196.21 9.89 196.21 180.01 9.00
PBIDTM(%) -96.17 -36.75 161.65 -96.17 -36.75 161.65 -31.58 -54.67 -42.24
Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..